Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Teva
Healthtrust
Mallinckrodt
Citi
Cerilliant
US Army
Baxter
Federal Trade Commission

Generated: April 19, 2018

DrugPatentWatch Database Preview

SCANLUX-300 Drug Profile

« Back to Dashboard

Which patents cover Scanlux-300, and when can generic versions of Scanlux-300 launch?

Scanlux-300 is a drug marketed by Sanochemia Corp Usa and is included in one NDA.

The generic ingredient in SCANLUX-300 is iopamidol. There are eleven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the iopamidol profile page.
Drug patent expirations by year for SCANLUX-300
Medical Subject Heading (MeSH) Categories for SCANLUX-300
Synonyms for SCANLUX-300
(S)-N,N'-bis(2-Hydroxy-1-(hydroxymethyl)ethyl)-2,4,6-triiodo-5-lactamidoisophthalamide
(S)-N,N'-Bis(2-hydroxy-1-(hydroxymethyl)ethyl)-5-((2-hydroxy-1-oxopropyl)amino)-2,4,6-triiodoisophthaldiamide
(S)-N,N'-Bis[2-hydroxy-1-(hydroxymethyl)ethyl]-2,4,6-triiodo-5-lactamidoisophthalamide
(S)-N,N'-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-5-[(2-hydroxy-1-oxopropyl)amino]-2,4,6-triiodo-1,3-benzenedicarboxamide
1-N,3-N-bis(1,3-dihydroxypropan-2-yl)-5-[[(2S)-2-hydroxypropanoyl]amino]-2,4,6-triiodobenzene-1,3-dicarboxamide
1,3-Benzenedicarboxamide, N,N'-bis(2-hydroxy-1-(hydroxymethyl)ethyl)-5-(((2S)-2-hydroxy-1-oxopropyl)amino)-2,4,6-triiodo-
1,3-Benzenedicarboxamide, N,N'-bis(2-hydroxy-1-(hydroxymethyl)ethyl)-5-((2-hydroxy-1-oxopropyl)amino)-2,4,6-triiodo-, (S)-
166I930
60166-93-0
62883-00-5
AB00513941
AB00513941_02
AC1L23CM
AC1Q4PBP
ACT03261
AKOS015891034
AN-39478
API0003016
B 15000
B-15000
BPBio1_001037
BRD-K75868704-001-01-2
BRN 6250226
BSPBio_000941
C-23510
CAS-60166-93-0
CC-29575
CCG-213024
CHEBI:31711
CHEMBL1200932
CS-2917
D01797
D0O2HQ
DB08947
DR003545
DSSTox_CID_3158
DSSTox_GSID_23158
DSSTox_RID_76896
DTXSID1023158
EINECS 262-093-6
FT-0627281
Gastromiro
GP4065
HMS1570P03
HMS2097P03
HSDB 8075
HY-B0684
I01-8407
iomapidol
iopamidol
Iopamidol (JP17/USP)
Iopamidol [USAN:INN:BAN:JAN]
Iopamidol [USAN:USP:INN:BAN:JAN]
Iopamidol 300
Iopamidol injection (JP17)
Iopamidol-200
Iopamidol-200 in plastic container
Iopamidol-250
Iopamidol-250 in plastic container
Iopamidol-300
Iopamidol-300 in plastic container
Iopamidol-370
Iopamidol-370 in plastic container
Iopamidolum
Iopamidolum [INN-Latin]
Iopamiro
Iopamiro 370
Iopamiron
Iopamiron (TN)
Iopamiron 300
Iopamiron 370
Iopamyron
Isovue
Isovue (TN)
Isovue 370
Isovue-128
Isovue-200
Isovue-250
Isovue-300
Isovue-370
Isovue-M 200
Isovue-M 300
Jopamiro
Jopamiron 200
JR13W81H44
KS-1421
L-(+)-N,N'-Bis(2-hydroxy-1-hydroxymethylethyl)-2,4,6-triiodo-5-lactamide isophthalamide
L-5alpha-Hydroxypropionylamino-2,4,6-triiodoisophthalic acid di(1,3-dihydroxy-2-propylamide)
L-5alpha-Idrossipropionilamino-2,4,6-triiodoisoftal-di(1,3-diidrossi-2-propilamide)
LS-29730
MolPort-003-848-224
N,N inverted exclamation mark -Bis[2-hydroxy-1-(hydroxymethyl)ethyl]-5-[[(2S)-2-hydroxy-1-oxopropyl]amino]-2,4,6-triiodo-1,3-benzenedicarboxamide
N,N'-bis(1,3-dihydroxypropan-2-yl)-5-{[(2S)-2-hydroxypropanoyl]amino}-2,4,6-triiodobenzene-1,3-dicarboxamide
N,N'-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-5-{[(2S)-2-hydroxypropanoyl]amino}-2,4,6-triiodobenzene-1,3-dicarboxamide
N1,N3-bis(1,3-dihydroxypropan-2-yl)-5-[(2S)-2-hydroxypropanamido]-2,4,6-triiodobenzene-1,3-dicarboxamide
N1,N3-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-5-[[(2S)-2-hydroxypropanoyl]amino]-2,4,6-triiodo-benzene-1,3-dicarboxamide
NCGC00016892-01
NCGC00016892-02
NCGC00016892-04
Niopam
Niopam 300
NSC-759636
NSC759636
Oypalomin
Pharmakon1600-01502304
Prestwick0_000871
Prestwick1_000871
Prestwick2_000871
Prestwick3_000871
Q-201245
s4532
SC-43948
Scanlux-370
SCHEMBL27781
Solutrast
Solutrast 370
SPBio_002862
SQ 13,396
SQ 13396
SQ-13396
Tox21_110668
Tox21_110668_1
UNII-JR13W81H44
XQZXYNRDCRIARQ-LURJTMIESA-N
ZINC3830947

US Patents and Regulatory Information for SCANLUX-300

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanochemia Corp Usa SCANLUX-300 iopamidol INJECTABLE;INJECTION 090394-001 Jun 18, 2010 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Federal Trade Commission
Teva
Chubb
AstraZeneca
McKesson
Medtronic
Argus Health
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.